Inventure Growth & Securities Q3 FY26: Profitability Surges But Structural Weaknesses Persist

Despite this impressive quarterly performance, the company's overall financial health remains concerning. With an average return on equity of just 4.98% and a latest ROE of merely 1.41%, Inventure Growth struggles to generate meaningful returns for shareholders. The stock currently trades at a price-to-book value of 0.45x, significantly below its book value of ₹2.60 per share, indicating deep market scepticism about the company's ability to sustain profitability.

The company's quality grade remains "Below Average" based on long-term financial performance, and its Mojo Score stands at a concerning 31 out of 100, placing it firmly in "SELL" territory. The stock has underperformed its Capital Markets sector peers by a massive 59.63 percentage points over the past year, raising questions about management execution and competitive positioning.

Financial Performance: Strong Quarter Masks Volatile History

In Q3 FY26, Inventure Growth & Securities reported net sales of ₹16.32 crores, marking a robust 40.93% year-on-year growth and a 23.45% quarter-on-quarter increase from ₹13.22 crores in Q2 FY26. This revenue acceleration represents a significant improvement after the company experienced a 13.54% decline in Q2 FY26 compared to the previous year.

The operating margin excluding other income expanded dramatically to 43.01% in Q3 FY26 from 15.43% in the previous quarter, demonstrating improved operational efficiency. The PAT margin of 25.33% represents a substantial improvement from 7.14% in Q2 FY26, though it remains below the exceptional 37.02% achieved in Q1 FY25. Operating profit before depreciation, interest, and tax (PBDIT) excluding other income stood at ₹5.23 crores, up from ₹1.73 crores quarter-on-quarter.

However, the quarterly volatility in profitability raises concerns about the sustainability of earnings. The company swung from a loss of ₹2.26 crores in Q4 FY25 to profits of ₹5.31 crores in Q1 FY26, then dropped sharply to ₹0.80 crores in Q2 FY26 before recovering to ₹3.08 crores in Q3 FY26. This erratic pattern suggests that the business model lacks stability and predictability.

Operational Challenges: Weak Returns and Profitability Concerns

The most glaring weakness in Inventure Growth's financial profile is its anaemic return on equity. The average ROE over recent years stands at just 4.98%, far below the double-digit returns expected from healthy capital markets businesses. The latest ROE of 1.41% is particularly concerning, indicating that the company generates barely more than one rupee of profit for every hundred rupees of shareholder equity deployed.

When examining the annual performance, the picture becomes even more troubling. In FY25, the company reported net sales of ₹60.00 crores, flat compared to FY24, with net profit collapsing to just ₹2.00 crores from ₹11.00 crores the previous year – an 81.82% decline. The PAT margin for FY25 stood at a meagre 3.30%, down from 18.30% in FY24, highlighting severe margin compression.

The balance sheet reveals a shareholder equity base of ₹272.67 crores as of March 2025, up from ₹221.56 crores in the previous year, primarily due to a capital increase that raised share capital from ₹84.00 crores to ₹105.00 crores. However, the company has minimal long-term debt and maintains a low debt-to-equity ratio of 0.10, which represents one of the few bright spots in the financial structure.

Employee costs in Q3 FY26 stood at ₹2.55 crores, up from ₹2.09 crores in Q2 FY26, indicating controlled personnel expenses. Interest costs of ₹1.01 crores in Q3 FY26 increased from ₹0.71 crores in the previous quarter, though they remain manageable given the low leverage profile.

Capital Markets Sector Context: Lagging Peers Significantly

The capital markets sector has witnessed strong performance over the past year, with the sector index delivering 27.43% returns. However, Inventure Growth has dramatically underperformed, posting a negative 32.20% return over the same period – an underperformance of 59.63 percentage points. This substantial gap reflects deep-seated operational issues and loss of investor confidence.

The company's high beta of 1.50 indicates that it is 50% more volatile than the broader market, amplifying both gains and losses. With the stock currently in a bearish technical trend and trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), the technical picture reinforces the fundamental weaknesses.

Peer Comparison: Valuation Discount Reflects Quality Concerns

When compared to listed peers in the capital markets space, Inventure Growth's valuation metrics paint a picture of significant undervaluation – but for good reason. The company trades at a P/E ratio of 32.11x, higher than most peers despite inferior fundamentals, suggesting that even at these depressed absolute price levels, the stock may not represent value.

Inventure Growth's ROE of 4.98% ranks at the bottom of the peer group, with competitors like Swastika Investment delivering 16.77% and Dharni Capital achieving 15.82%. The price-to-book ratio of 0.45x is the lowest in the group, reflecting market concerns about asset quality and earnings sustainability. Most peers trade at P/BV ratios above 1.0x, with Dharni Capital commanding a premium 5.76x multiple.

The company's market capitalisation of ₹120.00 crores positions it as the fifth-largest among the peer group, firmly in micro-cap territory where liquidity constraints and execution risks are magnified. With zero institutional holdings and no dividend payments (the last dividend of ₹0.20 per share was paid in September 2019), the stock lacks the support of sophisticated investors and offers no income component to offset capital depreciation.

Valuation Analysis: Deep Discount but Value Trap Risk

At the current price of ₹1.20, Inventure Growth trades at a significant 54% discount to its book value of ₹2.60 per share. The stock's EV/EBITDA multiple of 3.47x and EV/Sales ratio of 0.64x appear optically cheap compared to historical norms. However, these low multiples reflect genuine concerns about earnings quality and business sustainability rather than representing an attractive entry point.

The company's valuation grade has fluctuated wildly between "Very Attractive" and "Very Expensive" over the past six months, with the most recent assessment being "Very Attractive." This volatility in valuation assessment mirrors the underlying earnings instability and suggests that traditional valuation metrics may not be reliable indicators for this stock.

The stock currently trades 35.48% below its 52-week high of ₹1.86 and 26.32% above its 52-week low of ₹0.95. This positioning suggests that whilst the stock has recovered from its worst levels, it remains far from regaining investor confidence. The absence of any dividend yield further diminishes the total return proposition.

Shareholding Pattern: Stable but Lacking Institutional Support

The shareholding structure of Inventure Growth reveals a concerning lack of institutional participation. Promoter holding has remained stable at 26.40% across the last five quarters, with Kanji Bachubhai Rita holding 26.39% and Kanji Bhachu Rita HUF holding 0.01%. The absence of any pledging of promoter shares is a positive factor, indicating no immediate financial stress at the promoter level.

However, the complete absence of mutual fund holdings, insurance company participation, and other domestic institutional investor interest is a significant red flag. Foreign institutional investors, who held a minimal 0.14% stake in December 2024, have completely exited their position by December 2025. This institutional exodus signals a lack of confidence in the company's prospects among sophisticated investors who conduct thorough due diligence.

The non-institutional holding of 73.60% indicates that the stock is primarily held by retail investors and non-institutional entities, which can lead to higher volatility and limited price discovery. The absence of institutional support also means the stock lacks the stability and research coverage that typically accompanies institutional ownership.

Stock Performance: Severe Underperformance Across All Timeframes

The stock's price performance has been dismal across virtually all time periods. Over the past year, Inventure Growth has declined 32.20% whilst the Sensex gained 9.85%, resulting in a negative alpha of 42.05 percentage points. The two-year performance shows a 58.40% decline against the Sensex's 17.73% gain, and the three-year returns stand at negative 45.27% versus the Sensex's positive 37.89%.

The only positive note comes from the recent short-term performance, with the stock gaining 4.35% over the past day and week, and posting a year-to-date return of 5.26%. However, this modest recovery must be viewed in the context of the stock's severe longer-term underperformance and the fundamental challenges facing the business.

The stock's risk-adjusted return of negative 0.84 over the past year, combined with high volatility of 38.26%, places it firmly in the "High Risk Low Return" category. The negative Sharpe ratio indicates that investors have not been compensated for the substantial risk they have taken by holding this stock.

Investment Thesis: Weak Fundamentals Overshadow Quarterly Recovery

The investment case for Inventure Growth & Securities is severely challenged by multiple structural weaknesses. Whilst the Q3 FY26 results show impressive sequential improvement, this must be viewed against a backdrop of extreme quarterly volatility, weak return metrics, and persistent underperformance relative to both peers and the broader market.

The company's average ROE of 4.98% and latest ROE of 1.41% represent fundamental profitability challenges that cannot be overlooked. In the capital markets business, where operational leverage and scalability are key success factors, Inventure Growth has consistently failed to demonstrate the ability to generate acceptable returns on shareholder capital.

The complete absence of institutional investors and the exit of the small FII stake that existed earlier in 2025 underscore the lack of conviction among professional investors. The stock's high beta of 1.50 and volatility of 38.26% make it unsuitable for risk-averse investors, whilst the negative risk-adjusted returns fail to compensate even aggressive investors for the risks taken.

Key Strengths & Risk Factors

Outlook: What to Watch